CECONI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 15332
EU - Europa 4141
AS - Asia 1998
SA - Sud America 15
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 1
Totale 21499
Nazione #
US - Stati Uniti d'America 15325
IT - Italia 1439
CN - Cina 1368
UA - Ucraina 1222
TR - Turchia 562
DE - Germania 520
GB - Regno Unito 364
FI - Finlandia 248
SE - Svezia 173
FR - Francia 65
PL - Polonia 31
BE - Belgio 16
VN - Vietnam 15
ES - Italia 12
IN - India 11
RU - Federazione Russa 11
KR - Corea 8
AU - Australia 7
CH - Svizzera 6
IR - Iran 6
AL - Albania 5
BR - Brasile 5
EU - Europa 5
ID - Indonesia 5
MX - Messico 5
NL - Olanda 5
CL - Cile 4
CO - Colombia 4
HK - Hong Kong 4
IE - Irlanda 4
JP - Giappone 4
RO - Romania 4
GE - Georgia 3
AM - Armenia 2
AT - Austria 2
CA - Canada 2
GR - Grecia 2
LT - Lituania 2
MY - Malesia 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BG - Bulgaria 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
MD - Moldavia 1
MM - Myanmar 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
SG - Singapore 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 21499
Città #
Woodbridge 2374
Fairfield 2367
Houston 1349
Jacksonville 1347
Seattle 984
Ashburn 959
Chandler 887
Ann Arbor 886
Wilmington 799
Cambridge 795
Izmir 432
Nanjing 410
Princeton 349
San Diego 232
Boardman 186
Beijing 146
Shenyang 135
Nanchang 119
Milan 87
Hebei 81
San Mateo 76
Changsha 70
Falls Church 68
Jiaxing 66
Rome 63
Ferrara 62
Tianjin 58
Jinan 57
Mountain View 47
Verona 42
Ningbo 39
Philadelphia 39
Zhengzhou 39
Bremen 38
Redwood City 37
Taizhou 36
Warsaw 30
Norwalk 27
Addison 25
Napoli 24
Indiana 22
London 22
Kunming 20
Naples 19
Des Moines 18
Orange 18
Chicago 16
Hangzhou 16
Brussels 15
Dearborn 14
Dong Ket 14
Genova 14
Guangzhou 14
Bologna 12
Changchun 11
Florence 11
New York 11
Redmond 11
Bari 10
Shanghai 10
Palermo 9
Torino 9
Brescia 8
Yellow Springs 8
Auburn Hills 7
Catania 7
Haikou 7
Lanzhou 7
Los Angeles 7
Padova 7
Modena 6
Washington 6
Cagliari 5
Caserta 5
Como 5
Fuzhou 5
Livorno 5
Monmouth Junction 5
Pozzo Di Gotto 5
Siena 5
Genoa 4
Granada 4
Leawood 4
Omegna 4
Parma 4
Pisa 4
Ravenna 4
Trento 4
Bacoli 3
Bellinzago Novarese 3
Casalgrande 3
Domaso 3
Figline Valdarno 3
Helsinki 3
Latina 3
Liebenau 3
Marsala 3
Pescara 3
Reggio Nell'emilia 3
San Francisco 3
Totale 16361
Nome #
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 153
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion. 148
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL 144
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 134
Enhanced expression and activity of xanthine oxidoreductase in the failing heart. 131
Uric acid and coronary artery disease: An elusive link deserving further attention 128
Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium. 126
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 126
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). 119
Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients. 110
Third Universal Definition of Myocardial Infarction 110
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy 109
A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines 108
Postinfarction left ventricular free wall rupture: original management and surgical technique. 107
null 106
null 106
Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? 105
Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 105
Link between chronic obstructive pulmonary disease and coronary artery disease: Implication for clinical practice 104
Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression 104
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 104
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals 104
Effects of iloprost (ZK 36374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts. 103
Specific properties and effect of perindopril in controlling the renin-angiotensin system. 103
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 103
Abnormalities of left ventricular function in asymptomatic patients with systemic sclerosis using doppler measures of myocardial strain. 103
In vitro administration of ergothioneine failed to protect isolated ischaemic and reperfused rabbit heart 103
Right heart failure chronically stimulates heat shock protein 72 in heart and liver but not in other tissues. 103
Effects of endotoxic shock on neuronal NOS and calcium transients in rat cardiac myocytes 103
2015 ESC Guidelines for the diagnosis and management of pericardial diseases The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS) 103
Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE 103
Occurrence of oxidative stress during reperfusion of the human heart. 102
Is stunning an important component of preconditioning? 102
Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling. 102
Relevance of apoptosis in influencing recovery of hibernating myocardium 102
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation 102
Selective and specific I f inhibition with ivabradine: New perspectives for the treatment of cardiovascular disease 101
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association. 101
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 101
Plasma levels of atrial natriuretic factor (ANF) and urinary excretion of ANF, arginine vasopressin and catecholamines in children with congenital heart disease: effect of cardiac surgery. 100
Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies 100
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 100
Revascularization of hibernating myocardium: rate of metabolic and functional recovery and occurrence of oxidative stress. 99
Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability. 99
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). 99
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 99
Changes in oxidative stress and cellular redox potential during myocardial storage for transplantation: experimental studies. 98
Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive cardiac failure. 98
Effect of superoxide generation on rat heart mitochondrial pyruvate utilization. 98
Chromogranin A in heart failure - A novel neurohumoral factor and a predictor for mortality 98
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 98
Third universal definition of myocardial infarction 98
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction. 98
Incremental exercise using progressive versus constant pedaling rates: A study in cardlac patients 98
Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. 97
Oxygen free radicals and reperfusion injury; the effect of ischaemia and reperfusion on the cellular ability to neutralise oxygen toxicity. 97
Oxygen Free Radicals in Shock 97
Evidence against malondialdehyde bound to cellular constituents in phospholipid peroxidation 97
Anti-ischemic effect of IVA in isolated rabbit hearts: Modulation of cardiac metabolism 97
Anti-ischaemic effect of ivabradine 96
Traditional and new composite endpoints in heart failure clinical trials: Facilitating comprehensive efficacy assessments and improving trial efficiency 96
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: Study protocol for a randomized controlled trial 96
Role of A2A receptor in the modulation of myocardial reperfusion damage. 96
Effects of felodipine on the ischemic heart: insight into the mechanism of cytoprotection. 95
Left ventricular dysfunction due to stunning and hibernation in patients. 95
New insights on myocardial pyridine nucleotides and thiol redox state in ischemia and reperfusion damage. 95
Different outcomes of the reperfused myocardium: insights into the comments of stunning and hibernation. 95
Metabolic adaptation during a sequence of no-flow and low-flow ischemia. A possible trigger for hibernation. 95
Myocardial damage during ischaemia and reperfusion. 95
null 95
Mechanical vs. electrical dyssynchrony for CRTselection in patients with HF 95
Efficacy of Ivabradine in Combination with Beta-Blocker Versus Uptitration of Beta-Blocker in Patients with Stable Angina 95
Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition 95
Effect of L-carnitine derivatives on heart mitochondrial damage induced by lipid peroxidation. 95
Oxidative stress during myocardial ischaemia and heart failure. 94
Protective effect of a prostacyclin-mimetic on the ischaemic-reperfused rabbit myocardium. 94
Metabolic changes during post-ischaemic reperfusion. 94
The ACE-inhibitor Perindoprilat has high selectivity for bradykinin binding sites of human somatic ACE 94
null 94
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). 94
null 94
Cardioprotection by nisoldipine: role of timing of administration. 93
The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria. 93
One heart, two lungs together forever 93
Preventive cardiology: comparisons of European and Italian projects with the Cardiac Units from Emilia Romagna region. A workshop of IACPR/GICR - Emilia Romagna 93
The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine. 93
Continuous versus intermittent warm blood cardioplegia: functional and energetics changes. 93
Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease 93
Myocardial recovery during post-ischaemic reperfusion: effects of nifedipine, calcium and magnesium. 92
Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure. 92
The occurrence of oxidative stress during reperfusion in experimental animals and men. 92
Protective effect of propionyl-L-carnitine against ischaemia and reperfusion-damage. 92
The ACE-inhibitor perindoprilat has high selectivity for bradykinin binding sites of human somatic ACE 92
Effect of ivabradine on structural and electrophysiological remodelling in a rat model of heart failure 92
Guidelines on myocardial revascularization 92
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review 92
Ace inhibition with perindopril and markers of atherosclerosis and thrombosis: Results of the pertinent study 92
Left ventricular dysfunction due to the new ischemic outcomes: stunning and hibernation. 92
Lipid peroxidation in normal pregnancy and preeclampsia 91
Totale 11498
Categoria #
all - tutte 39183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2459
Totale 41642

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018264 0000 00 00 351683625
2018/20193770 341746175 4034 33928 2466078201384
2019/20205399 881186185803 419606 454585 418577165120
2020/20213361 295343198452 178362 78437 76438353151
2021/20222999 8537430682 107137 167151 1001872621041
2022/20232011 2772978259 391382 61251 283000
Totale 21745